Glioblastoma—more questions than answers?
- 1 February 2006
- journal article
- Published by Springer Nature in Nature Clinical Practice Oncology
- Vol. 3 (2) , 60-61
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Molecular Determinants of the Response of Glioblastomas to EGFR Kinase InhibitorsNew England Journal of Medicine, 2005
- Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to ErlotinibJNCI: Journal of the National Cancer Institute, 2005
- MGMTGene Silencing and Benefit from Temozolomide in GlioblastomaNew England Journal of Medicine, 2005
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: Case studyNeuro-Oncology, 2005
- Genetic Pathways to GlioblastomaCancer Research, 2004
- The Prognostic Significance of Phosphatidylinositol 3-Kinase Pathway Activation in Human GliomasJournal of Clinical Oncology, 2004
- Targeted radiotherapy of brain tumoursBritish Journal of Cancer, 2004
- Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trialsThe Lancet, 2002